Gefitinib-Induced Paronychia | Zendy

SoonHyo Kwon | Zendy; Jae Woo Choi | Zendy; Jong-Soo Hong | Zendy; Sang-Young Byun | Zendy; KyoungChan Park | Zendy; Sang Woong Youn | Zendy; ChangHun Huh | Zendy; JungIm Na | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gefitinib-Induced Paronychia

Author(s) -

SoonHyo Kwon,

Jae Woo Choi,

Jong-Soo Hong,

Sang-Young Byun,

KyoungChan Park,

Sang Woong Youn,

ChangHun Huh,

JungIm Na

Publication year - 2012

Publication title -

archives of dermatology

Language(s) - English

Resource type - Journals

eISSN - 1538-3652

pISSN - 0003-987X

DOI - 10.1001/archdermatol.2012.3022

Subject(s) - paronychia , gefitinib , medicine , dermatology , antibiotics , granulation tissue , surgery , epidermal growth factor receptor , wound healing , cancer , microbiology and biotechnology , biology

Paronychia has been reported in as many as 10% of patients treated with gefitinib. Although conservative management and treatment with topical or systemic antibiotics are beneficial, no effective method exists for intractable cases. Platelet-rich plasma (PRP)consists of a high concentration of platelets that promote wound healing through chemotaxis, cell proliferation,angiogenesis, and tissue remodeling.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research